KIM CHURACH: Open Payments
NPI 1740462043 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,799 in 212 payments from 25 companies in 2025. Trend: 2023 $1,745 · 2024 $4,126 · 2025 $4,799
Food & beverage: $4,787Education: $11
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 41 | $1,020 |
| GENZYME CORPORATION | 22 | $619 |
| GlaxoSmithKline, LLC. | 22 | $382 |
| Verona Pharma, Inc. | 20 | $321 |
| Actelion Pharmaceuticals US, Inc. | 12 | $279 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $237 |
| Insmed, Inc. | 7 | $232 |
| Regeneron Healthcare Solutions, Inc. | 13 | $220 |
| Lilly USA, LLC | 7 | $186 |
| Viatris Specialty LLC | 11 | $167 |
Products named: DUPIXENT, FASENRA, Ohtuvayre, LUMRYZ, Arikayce, BREZTRI, NUCALA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
